Overview Fundamentals API Earnings EOD API Sample Code Pricing

Dimerix Ltd (DXB AU) stock market data APIs

A$0.38 0(0%) as of September 19, 2024
Price chart is built with Anychart

Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia. The company develops DMX-200, a Phase 3 clinical trial for focal segmental glomerulosclerosis disease; DMX-200 which is in phase 2 clinical trial for diabetic kidney disease; DMX-200 for ARDS associated with COVID-19; and DMX-700 for chronic obstructive pulmonary disease, as well as develops proprietary receptor- HIT assay technology. Dimerix Limited is headquartered in Fitzroy, Australia.

Dimerix Ltd Financial Data Overview

0.38
0.38
-
0.385
0.37
0.061-0.665
214 M
557 M
583 K
0.533
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'DXB',
Type: 'Common Stock',
Name: 'Dimerix Ltd',
Exchange: 'AU',
CurrencyCode: 'AUD',
CurrencyName: 'Australian Dollar',
CurrencySymbol: 'A$',
CountryName: 'Australia',
CountryISO: 'AU',
OpenFigi: 'BBG000BQ98S2',
ISIN: 'AU000000DXB7',
CIK: NULL,
EmployerIdNumber: '',
FiscalYearEnd: 'June',
IPODate: NULL,
InternationalDomestic: 'International',
Sector: 'Healthcare',
Industry: 'Biotechnology',
}

Dimerix Ltd Fundamental Data is available in our Financial Data APIs

  • Net Revenue 583 K
  • EBITDA -17 068 810
  • Earnings Per Share -0.04
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Dimerix Ltd Earnings via APIs

  • Latest Release 2024-08-29
  • EPS/Forecast NaN

Get Dimerix Ltd End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com